Facebook-f Twitter Instagram Podcast Youtube Tiktok Linkedin-in Pinterest Envelope Share
CLICK HERE TO SHARE YOUR STORY!
  • About
    • Meet Our Contributors
    • Meet Our Partners
    • Meet the Patient Worthy Team
    • Collaborative Content On Patient Worthy
  • Diseases
  • Share Your Story
    • Patient Worthy Content Submission Guidelines
    • Patient Worthy Writing Prompts
    • Submit Your Story
    • Patient Stories
  • Resources
    • Library
    • Events
    • Patient Worthy FAQs
  • Podcast
  • Contact
Menu
  • About
    • Meet Our Contributors
    • Meet Our Partners
    • Meet the Patient Worthy Team
    • Collaborative Content On Patient Worthy
  • Diseases
  • Share Your Story
    • Patient Worthy Content Submission Guidelines
    • Patient Worthy Writing Prompts
    • Submit Your Story
    • Patient Stories
  • Resources
    • Library
    • Events
    • Patient Worthy FAQs
  • Podcast
  • Contact
  • Join PW

1467 Search Results Found

You searched for: "study of the week"
  1. Home>
  2. Search results for “study of the week”>
  3. Page 70
ICYMI: FDA Approves Tecentriq for Alveolar Soft Part Sarcoma

ICYMI: FDA Approves Tecentriq for Alveolar Soft Part Sarcoma

  While alveolar soft part sarcoma (ASPS) is considered to be relatively slow-growing, it is necessary to carefully manage this rare soft tissue sarcoma to avoid metastasizing. Surgery is one…

Continue Reading ICYMI: FDA Approves Tecentriq for Alveolar Soft Part Sarcoma
Hypoparathyroidism: Positive Results from Phase 2a Trial

Hypoparathyroidism: Positive Results from Phase 2a Trial

Globe Newswire recently published an article announcing positive results from Amolyt Pharma’s Phase IIa proof of concept clinical trial of AZP-3601. Amolyt Pharma, Cambridge, Massachusetts, and Lyon, France, is a…

Continue Reading Hypoparathyroidism: Positive Results from Phase 2a Trial
New Immunotherapy Proves Successful in 73 Percent of Multiple Myeloma Patients, (Part 1)

New Immunotherapy Proves Successful in 73 Percent of Multiple Myeloma Patients, (Part 1)

Part 1 Newswise recently published exciting news of a therapy that causes the immune system to destroy cancer cells in the bone marrow. Researchers at Icahn School’s Tisch Cancer Center…

Continue Reading New Immunotherapy Proves Successful in 73 Percent of Multiple Myeloma Patients, (Part 1)
How Wendy Borsari Translated Her Hypertrophic Cardiomyopathy Diagnosis into Impact (Pt. 2)

How Wendy Borsari Translated Her Hypertrophic Cardiomyopathy Diagnosis into Impact (Pt. 2)

Before you read on, don't forget to check out Part 1 of our interview. In Part 1, Wendy discusses what hypertrophic cardiomyopathy (HCM) is, her rare variant, the diagnostic journey, and her…

Continue Reading How Wendy Borsari Translated Her Hypertrophic Cardiomyopathy Diagnosis into Impact (Pt. 2)
Positive Phase 2 Data Available on IONIS-FB-LRx for IgAN

Positive Phase 2 Data Available on IONIS-FB-LRx for IgAN

  The American Society of Nephrology held its annual Kidney Week from November 3-6, 2022. During this week, multiple stakeholders within the nephrology sphere met to discuss trends, clinical care…

Continue Reading Positive Phase 2 Data Available on IONIS-FB-LRx for IgAN
Pancreatic Cancer Patients in the Phase 2 OCLURANDOM Trial See a Twelve Month Progression-Free Survival of 80 Percent

Pancreatic Cancer Patients in the Phase 2 OCLURANDOM Trial See a Twelve Month Progression-Free Survival of 80 Percent

Medscape Medical News reports that results have been received from the OCCLURANDOM Phase 2 trial which is the first randomized trial investigating the antitumor effect of the peptide receptor radionuclide…

Continue Reading Pancreatic Cancer Patients in the Phase 2 OCLURANDOM Trial See a Twelve Month Progression-Free Survival of 80 Percent
PRRT and OCLU Improved Progression-Free Survival for Pancreatic Cancer

PRRT and OCLU Improved Progression-Free Survival for Pancreatic Cancer

Are there therapeutic options for patients living with unresectable (inoperable) pancreatic cancer? According to an article in MedScape, researchers sought to understand whether sunitinib or a combination of peptide receptor…

Continue Reading PRRT and OCLU Improved Progression-Free Survival for Pancreatic Cancer
Hepatic Encephalopathy: Is Dementia a Common Misdiagnosis?

Hepatic Encephalopathy: Is Dementia a Common Misdiagnosis?

In the medical world, it’s no secret that misdiagnoses happen. But these misdiagnoses can be costly; patients may miss out on earlier treatment and prevention, and misdiagnosis may correlate with…

Continue Reading Hepatic Encephalopathy: Is Dementia a Common Misdiagnosis?
  • Go to the previous page
  • 1
  • …
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • …
  • 184
  • Go to the next page
Finding Light Through Story-The Power of Ambassadorship in the Endometrial Cancer Community
*cancer that cannot be removed with surgery or has spread to other parts of the body. GEJ= gastroesophageal junction (where the esophagus joins the stomach)
CLICK HERE TO SHARE YOUR STORY!
We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.
Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Partner With Us
Submit a Story

Keep Up to Date

Subscribe to Our Newsletter
Check Out Rare Events
Get Inspired By Our Memes

Learn More

About Us
Rare Diseases and Conditions
Terms of Use
Privacy Notice
Privacy Policy for CA Residents
EU/UK Privacy Notice
Data Privacy Framework: Consumer Privacy Policy
Consumer Health Data Privacy Policy
Cookie Notice

Facebook-f Twitter Instagram Podcast Youtube Tiktok Linkedin-in Pinterest Envelope

© Copyright 2024 Patient Worthy

Sign Up With a Patient Worthy Account and Share Your Rare Story

- OR -

Sign Up For Our Patient Panel

Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.

More Info

We're Happy You're Here!

What best describes you when it comes to rare disease? (check all that apply)

What rare disease(s)/conditions are most important to you?

Visit Home Page or

Thank you for signing up for a Patient Worthy Account!

Have a rare disease story to share? Let us know

Share Story

- OR -

Sign Up For Our Patient Panel

Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.

More Info